Alaunos Therapeutics (TCRT) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $2.18, +5.31% vs the prior close of $2.07.
- Volume 15.39M shares, 2.0x its 50-day average (heavy).
- New SEC filings: SCHEDULE 13D/A (Oct 15, 2026), 3 (Oct 15, 2026), SCHEDULE 13D (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
TCRT jumps 5.3% to $2.18 on 2.0x normal volume. Closed at $2.18, +5.31% vs the prior close of $2.07. Day range $1.80–$2.39, opened at $2.03.
TCRT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — TCRT jumps 5.3% to $2.18 on 2.0x normal volume
- Closed at $2.18, +5.31% vs the prior close of $2.07. Day range $1.80–$2.39, opened at $2.03.
- Volume was 15.39M shares, 2.0x its 50-day average of 7.59M — unusually heavy trading.
- Price is +43.6% vs its 50-day average ($1.52) and -7.9% vs its 200-day average ($2.37).
- 52-week range $0.72–$4.50; today's close sits at 39% of that range, 51.6% below the 52-week high.
Oct 14, 2026 — TCRT slides 31.7% to $2.07 on 11.0x normal volume
- Closed at $2.07, -31.68% vs the prior close of $3.03. Day range $1.88–$4.40, opened at $3.68.
- Volume was 68.56M shares, 11.0x its 50-day average of 6.22M — unusually heavy trading.
- Price is +36.6% vs its 50-day average ($1.52) and -12.8% vs its 200-day average ($2.37).
- 52-week range $0.72–$4.50; today's close sits at 36% of that range, 54.0% below the 52-week high.
Oct 13, 2026 — TCRT jumps 188.6% to $3.03, a 3-month high on 236.3x normal volume
- Closed at $3.03, +188.57% vs the prior close of $1.05. Day range $1.51–$4.32, opened at $1.73.
- Volume was 256.85M shares, 236.3x its 50-day average of 1.09M — unusually heavy trading.
- Price is +100.4% vs its 50-day average ($1.51) and +27.3% vs its 200-day average ($2.38).
- 52-week range $0.72–$4.50; today's close sits at 61% of that range, 32.7% below the 52-week high.
- That makes 3 straight gains.
- SEC filings that day: 8-K.
Oct 12, 2026 — TCRT jumps 32.9% to $1.05 on 3.4x normal volume
- Closed at $1.05, +32.91% vs the prior close of $0.79. Day range $0.77–$1.05, opened at $0.78.
- Volume was 3.42M shares, 3.4x its 50-day average of 1.02M — unusually heavy trading.
- Price is -29.5% vs its 50-day average ($1.49) and -55.9% vs its 200-day average ($2.38).
- 52-week range $0.72–$4.50; today's close sits at 9% of that range, 76.7% below the 52-week high.
Oct 9, 2026 — TCRT rises 1.3% to $0.79
- Closed at $0.79, +1.28% vs the prior close of $0.78. Day range $0.78–$0.80, opened at $0.80.
- Volume was 49.70K shares, 0.0x its 50-day average of 1.02M — lighter than usual.
- Price is -47.5% vs its 50-day average ($1.51) and -67.0% vs its 200-day average ($2.39).
- 52-week range $0.72–$4.59; today's close sits at 2% of that range, 82.8% below the 52-week high.
- SEC filings that day: 8-K.
Oct 8, 2026 — TCRT slides 7.1% to $0.78
- Closed at $0.78, -7.14% vs the prior close of $0.84. Day range $0.78–$0.85, opened at $0.84.
- Volume was 89.90K shares, 0.1x its 50-day average of 1.02M — lighter than usual.
- Price is -48.9% vs its 50-day average ($1.53) and -67.6% vs its 200-day average ($2.41).
- 52-week range $0.72–$4.59; today's close sits at 2% of that range, 83.0% below the 52-week high.
Oct 7, 2026 — TCRT jumps 13.5% to $0.84
- Closed at $0.84, +13.51% vs the prior close of $0.74. Day range $0.72–$0.89, opened at $0.74.
- Volume was 309.30K shares, 0.3x its 50-day average of 1.01M — lighter than usual.
- Price is -45.8% vs its 50-day average ($1.55) and -65.3% vs its 200-day average ($2.42).
- 52-week range $0.72–$4.59; today's close sits at 3% of that range, 81.7% below the 52-week high.
Oct 6, 2026 — TCRT slides 7.5% to $0.74, a 52-week low, 3 down days in a row
- Closed at $0.74, -7.50% vs the prior close of $0.80. Day range $0.72–$0.82, opened at $0.79.
- Volume was 121.10K shares, 0.1x its 50-day average of 1.01M — lighter than usual.
- Price is -52.9% vs its 50-day average ($1.57) and -69.7% vs its 200-day average ($2.44).
- 52-week range $0.72–$4.59; today's close sits at 1% of that range, 83.9% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — TCRT dips 2.4% to $0.80, a 52-week low
- Closed at $0.80, -2.44% vs the prior close of $0.82. Day range $0.78–$0.82, opened at $0.81.
- Volume was 48.10K shares, 0.0x its 50-day average of 1.01M — lighter than usual.
- Price is -49.8% vs its 50-day average ($1.60) and -67.4% vs its 200-day average ($2.45).
- 52-week range $0.78–$4.59; today's close sits at 1% of that range, 82.6% below the 52-week high.
Oct 2, 2026 — TCRT slides 10.9% to $0.82, a 52-week low
- Closed at $0.82, -10.87% vs the prior close of $0.92. Day range $0.82–$0.94, opened at $0.90.
- Volume was 86.50K shares, 0.1x its 50-day average of 1.01M — lighter than usual.
- Price is -49.3% vs its 50-day average ($1.62) and -66.8% vs its 200-day average ($2.47).
- 52-week range $0.82–$4.59; today's close sits at 0% of that range, 82.1% below the 52-week high.
TCRT latest news & SEC filings
Every SEC filing by or about TCRT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 15, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 15, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 3.02 — Sold unregistered shares.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Oct 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Weis Holger received an award of 23,564 shares at $0.74 (≈$17.54K) on Oct 6, 2026; now holds 49,047
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Vieser Jaime received an award of 22,669 shares at $0.74 (≈$16.87K) on Oct 6, 2026; now holds 70,311
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Postma Robert W received an award of 21,829 shares at $0.74 (≈$16.25K) on Oct 6, 2026; now holds 80,438
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Jerman Michael Allen received an award of 20,990 shares at $0.74 (≈$15.62K) on Oct 6, 2026; now holds 44,749
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Sep 21, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $0)
- Net income: -$952.00K (prior year -$1.05M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.41 (prior year -$0.63) (loss narrowed vs Jun 30, 2025)
Aug 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Things to know before you trade TCRT
- Last results release: Oct 10, 2024 (8-K Item 2.02). Previous ones: Nov 14, 2023, Aug 14, 2023, May 10, 2023. Based on that rhythm, the next report is likely around Jan 9, 2025 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 18.49% (largest 188.6%). That is a volatile stock.
- Liquidity: about 18.98M shares (≈$41.38M) trade per day on average.
- 52-week position: $2.18 vs a range of $0.72–$4.50 (39% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 13, 2026; 8-K Oct 9, 2026; 8-K Sep 22, 2026.
- Share count: 2.54M shares outstanding (Aug 14, 2026), +15.7% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
TCRT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 2.03 | 2.39 | 1.80 | 2.18 | 15.39M |
| Oct 14, 2026 | 3.68 | 4.40 | 1.88 | 2.07 | 68.56M |
| Oct 13, 2026 | 1.73 | 4.32 | 1.51 | 3.03 | 256.85M |
| Oct 12, 2026 | 0.78 | 1.05 | 0.77 | 1.05 | 3.42M |
| Oct 9, 2026 | 0.80 | 0.80 | 0.78 | 0.79 | 49.70K |
| Oct 8, 2026 | 0.84 | 0.85 | 0.78 | 0.78 | 89.90K |
| Oct 7, 2026 | 0.74 | 0.89 | 0.72 | 0.84 | 309.30K |
| Oct 6, 2026 | 0.79 | 0.82 | 0.72 | 0.74 | 121.10K |
| Oct 5, 2026 | 0.81 | 0.82 | 0.78 | 0.80 | 48.10K |
| Oct 2, 2026 | 0.90 | 0.94 | 0.82 | 0.82 | 86.50K |
| Oct 1, 2026 | 0.91 | 0.95 | 0.89 | 0.92 | 93.80K |
| Sep 30, 2026 | 0.95 | 1.00 | 0.85 | 0.89 | 125.80K |
| Sep 29, 2026 | 1.03 | 1.05 | 0.96 | 0.96 | 36.50K |
| Sep 28, 2026 | 1.06 | 1.10 | 0.97 | 1.02 | 149.20K |
| Sep 25, 2026 | 1.13 | 1.13 | 1.08 | 1.09 | 81.30K |
| Sep 24, 2026 | 1.14 | 1.16 | 1.10 | 1.13 | 196.90K |
| Sep 23, 2026 | 1.21 | 1.27 | 1.10 | 1.15 | 201.70K |
| Sep 22, 2026 | 1.19 | 1.34 | 1.17 | 1.27 | 360.90K |
| Sep 21, 2026 | 1.26 | 1.35 | 1.22 | 1.26 | 667.60K |
| Sep 18, 2026 | 1.57 | 1.60 | 1.02 | 1.20 | 32.77M |
About Alaunos Therapeutics
Alaunos Therapeutics (TCRT) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in FORT LAUDERDALE, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1107421.
TCRT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Michael Allen Jerman | Director | Jul 27, 2026 |
| Robert W Postma | Director | Jul 27, 2026 |
| Jaime Vieser | Director | Jul 27, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Holger Weis | CEO | Aug 11, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
TCRT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $5.00K | $-4.18M | -2.20 | $-2.87M |
| Dec 31, 2024 | $10.00K | $-4.68M | -2.92 | $-4.97M |
| Dec 31, 2023 | $5.00K | $-4.68M | -21.97 | $-30.14M |
| Dec 31, 2022 | $2.92M | $-37.73M | -2.61 | $-29.23M |
| Dec 31, 2021 | $398.00K | $-78.75M | -0.37 | $-61.47M |
Latest balance sheet: total assets $1.52M, total liabilities $864.00K, cash $124.00K (as of Jun 30, 2026).
TCRT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 10, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
| Aug 14, 2023 | 8-K Item 2.02 (results) | — |
| May 10, 2023 | 8-K Item 2.02 (results) | — |
| Mar 7, 2023 | 8-K Item 2.02 (results) | — |
| Nov 14, 2022 | 8-K Item 2.02 (results) | — |
| Aug 15, 2022 | 8-K Item 2.02 (results) | — |
| May 16, 2022 | 8-K Item 2.02 (results) | — |
| Mar 30, 2022 | 8-K Item 2.02 (results) | — |
| Aug 9, 2021 | 8-K Item 2.02 (results) | — |
| May 6, 2021 | 8-K Item 2.02 (results) | — |
| Feb 25, 2021 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)AMD (AMD)Apple (AAPL)Tesla (TSLA)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TCRT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.